Grants8

Grant Information	Key Details	Eligibility & Funding
Alternative Fuels Infrastructure Facility - Co-funding Rate CEF-T-2024-AFIFGEN-COSTS Programme: CEF 2 Transport - Alternative Fuels Infrastructure Facility - General envelope	This grant, part of the Alternative Fuels Infrastructure Facility (AFIF), aims to support the deployment of alternative fuel supply infrastructure to help decarbonize transport along Europe's Trans-European Transport Network (TEN-T). It's designed to facilitate the shift towards cleaner energy for heavy-duty vehicles, public transport, rail, maritime, and inland waterway vessels. This is a SECTOR-SPECIFIC grant, focusing exclusively on the energy and transport sectors, particularly for infrastructure development. The primary target recipients are organizations involved in the planning, development, and implementation of alternative fuel infrastructure. While specific organization types and sizes aren't detailed, the nature of the projects implies a focus on enterprises and public bodies with the capacity to undertake significant infrastructure projects, potentially collaborating with SMEs. The geographic scope is primarily the EU member states connected by the TEN-T network, though an exact list of eligible countries is not provided in the materials. This call has multiple cut-off dates, indicating a recurring opportunity within its active period.	Funding Up to 10000000.00 EUR Deadline March 4, 2026, midnight	Details
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) PAR-25-075 Programme: National Cancer Institute (NCI) / National Institutes of Health (NIH)	Core Objective: To accelerate the adoption and validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This grant is for clinical validation of established assays, not early-stage technology development or conduct of clinical trials. Target Recipient Type and Size: Broad range of organizations including higher education, nonprofits, for-profit entities (small and other businesses), and various government entities. No specific size limitations beyond general organizational capacity. SECTOR-SPECIFIC: Healthcare/Cancer Research Geographic Scope: United States-based organizations. Foreign organizations are not eligible to apply, but foreign components of U.S. organizations are allowed. Key Filtering Criteria: Applicant must have an assay(s) whose performance has been analytically validated in specimens similar to those for the intended clinical use. The project must not propose early-stage technology development or clinical trials. Grant Frequency and Program Context: This is a reissuance of a previous funding opportunity (PAR-23-314), indicating it is a recurring program. It uses the UH3 Exploratory/Developmental Cooperative Agreement Phase II mechanism, which implies substantial Federal scientific or programmatic involvement post-award.	Funding Up to 250000.00 USD Deadline Oct. 14, 2026, 5 p.m.	Details
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-25-233 Programme: National Institutes of Health (NIH) Funding Opportunity Announcements	This grant, the Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed), aims to fund small research projects. Its core objective is to identify, develop, and test strategies for successfully integrating evidence-based health interventions into real-world settings. It also supports research on how to stop using ineffective or harmful practices and on developing new methods for this type of research. This funding opportunity is SECTOR-SPECIFIC, focusing primarily on the health sector, including public health and clinical practice. It is designed for a wide range of organizations, from educational institutions and nonprofits to small businesses and government entities. The geographic scope is broad, covering both U.S. organizations and non-U.S. (foreign) entities. Key filtering criteria for this grant are its focus on researching implementation strategies (not testing the interventions themselves), its small grant (R03) mechanism with a limited budget, and the explicit exclusion of clinical trials. This is a recurring funding opportunity with multiple application deadlines each year until early 2028, reflecting an ongoing commitment from the National Institutes of Health (NIH) to bridge the gap between health research and practice.	Funding Up to 100000.00 USD Deadline Jan. 7, 2028, 5 a.m.	Details
Next generation aircraft autonomy technologies for cockpit / pilot assistance applications 48346582TOPICSen Programme: Horizon Europe	Core Objective: Develop next generation aircraft autonomy technologies for cockpit/pilot assistance applications. Target Recipient: Organizations and consortia involved in research and innovation within the aeronautics sector. SECTOR-SPECIFIC: TRANSPORTATION (Aviation/Aerospace). Geographic Scope: Organizations from EU Member States and countries associated with Horizon Europe (specific list not provided in these documents, refer to Annex B of the Work Programme General Annexes). The focus is on European civil aircraft. Key Filtering Criteria: Focus on aircraft autonomy, cockpit/pilot assistance, and the development of new technologies up to TRL 4. Grant Frequency: Part of the recurring Horizon Europe Work Programme (2021-2027), specifically Cluster 5 Call 03-2025. It aligns with the broader Clean Aviation Joint Undertaking's goals for climate-neutral aviation.	Funding Up to 3500000.00 EUR Deadline April 14, 2026, midnight	Details
DigiQ Exchange Program 7622COMPETITIVE_CALLen Programme: DigiQ: Digitally Enhanced European Quantum Technology Master	The core objective of the DigiQ Exchange Program is to provide financial support to Master's students in Quantum Technology, enabling them to undertake exchange semesters or thesis projects at partner institutions within the DigiQ network. - Target recipient type: Individual students, specifically those enrolled in a relevant Master Degree Programme. - Target recipient size: Individuals. - Designation: SECTOR-SPECIFIC (focused on Quantum Technology). - Geographic scope: European countries, specifically those where DigiQ partner institutions are located or eligible host countries are identified. - Key filtering criteria: Enrollment in a relevant Master's program, affiliation with or commitment to join the DigiQ network, and academic performance. - Grant frequency: The program runs year-round with ongoing applications until the program ends on September 30, 2026, making it a recurring opportunity.	Funding Up to 6120.00 EUR Deadline March 31, 2026, 5 p.m.	Details
Funding to Attend DigiQ Networking Events 7621COMPETITIVE_CALLen Programme: DigiQ: Digitally Enhanced European Quantum Technology Master	This grant provides financial support to students enrolled in or affiliated with the DigiQ network to attend in-person networking events. The core objective is to enhance the education and networking opportunities for students in the field of quantum technology. Target recipient type: Individual students. Target recipient size: N/A, as it targets individuals. This is a SECTOR-SPECIFIC grant, focused on quantum technology education and networking. Geographic scope: Students must be associated with a DigiQ partner institution located in one of the eligible European countries. Key filtering criteria for initial screening: Must be a student (current or recent graduate) affiliated with the DigiQ network. Grant frequency: Recurring until September 30, 2026, when the overall DigiQ program concludes. Program context: Part of the broader 'Digitally Enhanced European Quantum Technology Master' project (DigiQ), under the 'Specialised education programmes in key capacity areas' topic of the DIGITAL Europe Programme.	Funding Up to 1000.00 EUR Deadline Sept. 30, 2026, midnight	Details
Making food systems more resilient to food safety risks through the deployment of technological solutions HORIZON-CL6-2025-02-FARM2FORK-03-two-stage Programme: Horizon Europe	The core objective of this grant is to enhance the resilience of food systems to food safety risks by deploying advanced technological solutions. It aims to translate existing knowledge into marketable results and impactful applications. Target recipient: Organizations and actors across the entire food supply chain, including farming, raw materials suppliers, food processing, distribution, retail, and food services. SMEs are particularly encouraged. SECTOR-SPECIFIC: This grant is highly specific to the food systems sector, encompassing agriculture, fisheries, aquaculture, and the broader food industry. Geographic scope: Primarily EU Member States and countries associated with Horizon Europe. International cooperation is encouraged, especially with African partners, and engagement with widening countries, outermost regions, and Central/Eastern Europe is promoted. Key filtering criteria for initial screening: Applicants must focus on innovative technological solutions for food safety and/or food fraud, aiming for high Technology Readiness Levels (TRL 8 by project end), and utilizing a multi-actor approach for broad stakeholder involvement. Grant frequency: This opportunity is part of the Horizon Europe Work Programme 2025, indicating it is a recurring program within a larger funding framework.	Funding Up to 6000000.00 EUR Deadline Feb. 18, 2026, midnight	Details
Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders HORIZON-HLTH-2025-03-DISEASE-02-two-stage Programme: Horizon Europe	This grant, HORIZON-HLTH-2025-03-DISEASE-02-two-stage, aims to advance innovative interventions for mental, behavioural, and neurodevelopmental disorders. Its core objective is to support research and innovation actions that lead to new, more effective, and safer therapeutic and relapse-preventing solutions, including those based on active substances and complementary multidisciplinary approaches. The grant explicitly targets scientific and clinical communities, encouraging participation from start-ups, micro, small, and medium-sized enterprises (SMEs), as well as broader legal entities involved in research. This is a SECTOR-SPECIFIC grant, focusing primarily on healthcare, life sciences, and related technology within the domain of brain health and mental health. The geographic scope includes EU Member States, Associated Countries (as defined by Horizon Europe Annex B), and the United States of America. Key filtering criteria for initial screening include a focus on clinical studies, novel therapeutic approaches, digital health solutions (including AI), and strong stakeholder engagement. Projects focusing on rare diseases (as defined by the EU Orphan Medicinal Products Regulation) are explicitly excluded. This grant is part of the Horizon Europe 2025 Work Programme, suggesting it is a recurring opportunity within the broader framework.	Funding Up to 8000000.00 EUR Deadline April 16, 2026, midnight	Details
AI-Powered Signal Detection in Pharmacovigilance HORIZON-JU-IHI-2025-11-03-two-stage Programme: Innovative Health Initiative JU Call 11	Core Objective: To enhance drug safety and improve patient safety through the development and implementation of AI-powered signal detection and risk prediction methods in pharmacovigilance. Target Recipient Type: Legal entities, including research organizations, universities, SMEs, and large enterprises. Target Recipient Size: Not explicitly defined, open to various organizational sizes given the collaborative nature of research and innovation actions. SECTOR-SPECIFIC Geographic Scope: Primarily EU Member States and countries associated with Horizon Europe, excluding the UK and Canada for funding. Key Filtering Criteria: Projects must focus on applying Artificial Intelligence to pharmacovigilance, specifically for signal detection and risk prediction. Emphasis is on research and innovation activities that lead to practical guidance and tools. Grant Frequency and Program Context: This is a specific topic within the Innovative Health Initiative (IHI) Joint Undertaking's Call 11 (HORIZON-JU-IHI-2025-11-two-stage), which is part of the broader Horizon Europe framework. IHI calls are recurring within the Horizon Europe program.	Funding Up to 8906000.00 EUR Deadline April 29, 2026, midnight	Details
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed) PAR-24-259 Programme: Small Instrumentation Grants Program (S15)	Core objective: To fund the purchase of latest scientific equipment to enhance and modernize the operations of existing shared biomedical research facilities, ultimately strengthening auxiliary activities and improving efficiency. Target recipient type: Academic or research institutions. Target size: Not specified by employee count, but implicitly institutions with established shared facilities. Designation: SECTOR-SPECIFIC Geographic scope: United States. Key filtering criteria: Institution must operate an existing shared biomedical research facility, equipment must be for operational support (not direct scientific data acquisition), and only one type of equipment per application. Grant frequency: Recurring annually with multiple submission cycles until September 2026. Program context: Part of the NIH's S15 Small Instrumentation Grants Program.	Funding Up to 350000.00 USD Deadline Sept. 25, 2026, 5 p.m.	Details
Vet-LIRN Network Capacity-Building Project and Equipment Grants PAR-23-202 Programme: Department of Health and Human Services / U.S. Food and Drug Administration (FDA)	This grant, PAR-23-202, aims to fund veterinary diagnostic laboratories within the Vet-LIRN network for projects and equipment. The core objectives include supporting the development and validation of new methods related to animal food safety and antimicrobial resistance (AMR), conducting short-term monitoring, developing AMR stewardship projects, contributing to Vet-LIRN's AMR monitoring, and supporting One Health initiatives (e.g., emerging diseases, emergency surge capacity). This is a SECTOR-SPECIFIC grant primarily targeting established veterinary diagnostic laboratories. While not explicitly stated, the funding body (U.S. FDA) implies a U.S. geographic scope.	Funding Up to 2500000.00 USD Deadline April 16, 2028, 3:59 a.m.	Details
Research Project: Innovation Grant Onderzoeksproject: subsidie voor innovatie Programme: VLAIO Innovation Subsidies	The core objective of this grant is to support businesses in Flanders to conduct frontier research ('grensverleggend onderzoek') that builds new knowledge, insights, and skills, leading to significant long-term positive impact for the company and for Flanders. The grant targets enterprises with legal personality, non-profit organizations, and public organizations that undertake economic activity in the Flemish Region. This grant is SECTOR-AGNOSTIC, with no preference for specific sectors, application domains, or knowledge areas. Geographic scope is limited to organizations with operational activities (or clear intent to have them) in the Flemish Region of Belgium. Key filtering criteria include the innovative nature of the project (must clearly deviate from normal business activities), a focus on knowledge building, and the project's potential for significant positive impact and valorization in Flanders. This is a recurring grant program with applications being accepted on a permanent, open basis.	Funding Up to 3000000.00 EUR Deadline Nov. 4, 2025, 11 a.m.	Details
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) PAR-25-158 Programme: National Institutes of Health (NIH) Funding Opportunity	This grant, PAR-25-158, aims to fund research focused on preventing Fetal Alcohol Spectrum Disorders (FASD) by reducing prenatal alcohol exposure, and developing interventions for individuals affected by FASD throughout their lives. It supports biomedical, behavioral, and social sciences research, with a strong preference for applications that include clinical trials. This is a SECTOR-SPECIFIC grant targeting organizations capable of conducting research in the health and social sciences, specifically related to alcohol exposure and developmental disorders. The grant is open to a very broad range of organization types including academic institutions, non-profits, for-profits (including small businesses), and various government entities, both domestic and international. It is a recurring funding opportunity with multiple application cycles available until its expiration date in November 2026, and is a reissue of a previous funding opportunity, indicating continuity in program objectives.	Funding Up to 500000.00 USD Deadline Oct. 19, 2026, 10 p.m.	Details
VILNIUS TECH MERIT Project Re-/Up-skilling Scholarship Call 11262COMPETITIVE_CALLen Programme: DIGITAL-2021-SKILLS-01-SPECIALISED	This scholarship aims to promote lifelong learning and skill development in advanced digital areas for European citizens. It targets individuals who have completed specific short-term digital skills courses at VILNIUS TECH, encouraging re-skilling and up-skilling, especially for those without a prior ICT education or early graduates. This is a SECTOR-SPECIFIC grant focused on digital skills.	Funding Up to 1000.00 EUR Deadline May 1, 2026, 10 a.m.	Details
GREEN: steun voor groener en efficiënter energiegebruik GREEN Programme: VLAIO	The GREEN grant's core objective is to provide financial support to businesses in the Flemish Region that invest in transitioning from fossil fuels to green energy (vergroening and electrification) or in significantly improving the energy efficiency of their core industrial activities. This aims to reduce CO2 emissions and lower energy bills. The grant targets enterprises of all sizes, including SMEs, large companies, and non-profits with economic activity. It is SECTOR-AGNOSTIC in terms of the applicant's primary business but THEMATICALLY SPECIFIC to energy transition and efficiency within industrial processes. The geographic scope is strictly the Flemish Region of Belgium. Key filtering criteria include a minimum project cost of €50,000, and investments must go beyond legally required standards. The grant operates on an open call basis for the period 2023-2024, accepting applications until the end of 2025 or until the budget is exhausted.	Funding Up to 1000000.00 EUR Deadline Dec. 31, 2025, 10:59 p.m.	Details
Strengthening the EU crop breeding research and innovation ecosystem for competitive, resilient, and sustainable agriculture HORIZON-CL6-2025-02-FARM2FORK-09 Programme: Horizon Europe	The core objective of this grant is to strengthen the European Union's crop breeding research and innovation ecosystem. It aims to foster competitive, resilient, and sustainable agriculture by enhancing understanding of funding landscapes, establishing co-creative environments for stakeholders, supporting trans-national research and innovation cooperation, and facilitating market access for new crop varieties. - Target recipients: This grant targets a broad range of organizations including public and private entities, research institutions, universities, farmers, breeders, industry stakeholders (especially SMEs), NGOs, and civil society. - SECTOR-SPECIFIC: This grant is primarily focused on the AGRICULTURE and ENVIRONMENT sectors, with strong components in TECHNOLOGY and SOCIAL innovation. - Geographic scope: The primary geographic scope is within the EU Member States. There is a strong emphasis on considering the needs of all 27 EU Member States and encouraging international cooperation, particularly with the EU-Africa Partnership on food and nutrition security. - Key filtering criteria for initial grant screening: Focus on crop breeding, strengthening R&I ecosystems, promoting sustainable and resilient agriculture, and fostering multi-actor collaborations. - Grant frequency and program context: This is a single-stage call within the broader Horizon Europe Cluster 6 program, which typically issues recurring calls covering various aspects of food, bioeconomy, natural resources, agriculture, and environment.	Funding Up to 3000000.00 EUR Deadline Sept. 16, 2025, midnight	Details
Clinical and Translational Science Award (UM1 Clinical Trial Optional) PAR-24-272 Programme: Clinical and Translational Science Award (CTSA) Program	This grant aims to fund Clinical and Translational Science Award (CTSA) Program 'hubs,' which are integrated research and training environments. The core objective is to accelerate the translation of scientific discoveries into improved health outcomes for individuals and communities by fostering scientific and operational innovations in clinical and translational science. The primary target recipients are established medical research institutions and academic health centers, or non-profit research organizations that conduct clinical and translational research. They function as 'hubs' within a national consortium. The size is not defined by employee count but by their capacity to operate as a central institution with integrated research and training environments, potentially collaborating with multiple partner and collaborating institutions. This grant is SECTOR-AGNOSTIC in terms of disease or condition, focusing on the science of translation rather than specific diseases. However, it is research-specific, focusing on clinical and translational science. The geographic scope is the United States (domestic organizations only). Foreign components are allowed, but foreign organizations cannot apply as the prime recipient. Key filtering criteria include: applicant must be an eligible U.S.-based institution type, include a graduate school accredited in clinical/translational science, and commit at least two months of effort per PD/PI. This is a recurring funding opportunity (reissue of PAR-21-293) with multiple annual application deadlines, part of the broader National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) Program.	Funding Up to 6500000.00 USD Deadline Sept. 28, 2027, 9 p.m.	Details
VILNIUS TECH MERIT Project Excellence Scholarship and Mobility Grant Award Call 8123COMPETITIVE_CALLen Programme: DIGITAL-2021-SKILLS-01-SPECIALISED	This grant aims to promote the practical application, publicity, and research of advanced digital skills, particularly in Artificial Intelligence, among European citizens. It provides scholarships and mobility grants to foster innovation, activity, and mobility within these fields. - Target recipients: Individual students. - Target size: Not applicable (for individuals). - SECTOR-SPECIFIC - Geographic scope: EU citizens studying at Vilnius Gediminas Technical University (Lithuania). Mobility activities can cover international locations. - Key filtering criteria: EU citizenship, enrollment in specific VILNIUS TECH AI Master's programs, no academic debts. - Grant frequency: Recurring (applications considered monthly) until the program's final date (September 1, 2026). - Program context: Part of the MERIT project, which is co-funded by the European Union; however, this specific scholarship call is directly administered and funded by VILNIUS TECH, which holds sole responsibility.	Funding Up to 3000.00 EUR Deadline June 30, 2026, 7 p.m.	Details
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) PAR-24-306 Programme: National Institutes of Health (NIH)	This grant aims to expand, improve, or transform the utility of mammalian cancer and tumor models specifically for translational research. The core objective is to ensure these models are robust representations of human biology, appropriate for testing clinically important questions, and provide reliable information that ultimately benefits patients. It targets research organizations of various types and sizes, including higher education institutions, nonprofits, for-profit organizations (including small businesses), and various government entities, both within the U.S. and internationally. This is a SECTOR-SPECIFIC grant, focusing exclusively on oncology and cancer translational science. Key filtering criteria include the explicit focus on translational research using mammalian cancer models, and importantly, the grant is 'Clinical Trial Not Allowed', meaning applications proposing clinical trials will not be considered. Purely mechanistic research or the development of models for non-clinical research are also explicitly excluded. This is a recurring grant opportunity, as it is a reissue of a previous funding announcement, with multiple application deadlines extending through 2026.	Funding Up to 499000.00 USD Deadline July 5, 2026, 5 p.m.	Details
SmartUp powered by StartSmart CEE SmartUp powered by StartSmart CEE Programme: StartSmart Central Eastern Europe Acceleration Program	The 'SmartUp powered by StartSmart CEE' grant offers non-repayable financial support for technology startups. It focuses on two development paths: 'PilotReady Booster' for pilot implementation with corporate partners, and 'GoGlobal' for international market expansion into the USA or Germany. - Target Recipient Type: Startups, Micro and Small Enterprises. - Target Recipient Size: Micro and Small enterprises, as defined by EU regulations. - SECTOR-SPECIFIC: TECHNOLOGY sector. - Geographic Scope: Applicants must be based in Poland. The 'GoGlobal' path specifically targets market entry into the USA (Boston ecosystem) or Germany (Berlin ecosystem). - Key Filtering Criteria: Technology focus, startup status, micro/small enterprise size, and readiness for pilot implementation or international expansion. - Grant Frequency: The program operates in recurring rounds.	Funding Up to 400000.00 PLN Deadline Nov. 13, 2025, 11:59 p.m.	Details

Alternative Fuels Infrastructure Facility - Co-funding Rate

CEF-T-2024-AFIFGEN-COSTS

Programme: CEF 2 Transport - Alternative Fuels Infrastructure Facility - General envelope

This grant, part of the Alternative Fuels Infrastructure Facility (AFIF), aims to support the deployment of alternative fuel supply infrastructure to help decarbonize transport along Europe's Trans-European Transport Network (TEN-T). It's designed to facilitate the shift towards cleaner energy for heavy-duty vehicles, public transport, rail, maritime, and inland waterway vessels. This is a SECTOR-SPECIFIC grant, focusing exclusively on the energy and transport sectors, particularly for infrastructure development. The primary target recipients are organizations involved in the planning, development, and implementation of alternative fuel infrastructure. While specific organization types and sizes aren't detailed, the nature of the projects implies a focus on enterprises and public bodies with the capacity to undertake significant infrastructure projects, potentially collaborating with SMEs. The geographic scope is primarily the EU member states connected by the TEN-T network, though an exact list of eligible countries is not provided in the materials. This call has multiple cut-off dates, indicating a recurring opportunity within its active period.

Funding

Up to 10000000.00 EUR

Deadline

March 4, 2026, midnight

Details

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

PAR-25-075

Programme: National Cancer Institute (NCI) / National Institutes of Health (NIH)

Core Objective: To accelerate the adoption and validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This grant is for clinical validation of established assays, not early-stage technology development or conduct of clinical trials.
Target Recipient Type and Size: Broad range of organizations including higher education, nonprofits, for-profit entities (small and other businesses), and various government entities. No specific size limitations beyond general organizational capacity.
SECTOR-SPECIFIC: Healthcare/Cancer Research
Geographic Scope: United States-based organizations. Foreign organizations are not eligible to apply, but foreign components of U.S. organizations are allowed.
Key Filtering Criteria: Applicant must have an assay(s) whose performance has been analytically validated in specimens similar to those for the intended clinical use. The project must not propose early-stage technology development or clinical trials.
Grant Frequency and Program Context: This is a reissuance of a previous funding opportunity (PAR-23-314), indicating it is a recurring program. It uses the UH3 Exploratory/Developmental Cooperative Agreement Phase II mechanism, which implies substantial Federal scientific or programmatic involvement post-award.

Funding

Up to 250000.00 USD

Deadline

Oct. 14, 2026, 5 p.m.

Details

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

PAR-25-233

Programme: National Institutes of Health (NIH) Funding Opportunity Announcements

This grant, the Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed), aims to fund small research projects. Its core objective is to identify, develop, and test strategies for successfully integrating evidence-based health interventions into real-world settings. It also supports research on how to stop using ineffective or harmful practices and on developing new methods for this type of research. This funding opportunity is SECTOR-SPECIFIC, focusing primarily on the health sector, including public health and clinical practice. It is designed for a wide range of organizations, from educational institutions and nonprofits to small businesses and government entities. The geographic scope is broad, covering both U.S. organizations and non-U.S. (foreign) entities. Key filtering criteria for this grant are its focus on researching implementation strategies (not testing the interventions themselves), its small grant (R03) mechanism with a limited budget, and the explicit exclusion of clinical trials. This is a recurring funding opportunity with multiple application deadlines each year until early 2028, reflecting an ongoing commitment from the National Institutes of Health (NIH) to bridge the gap between health research and practice.

Funding

Up to 100000.00 USD

Deadline

Jan. 7, 2028, 5 a.m.

Details

Next generation aircraft autonomy technologies for cockpit / pilot assistance applications

48346582TOPICSen

Programme: Horizon Europe

Core Objective: Develop next generation aircraft autonomy technologies for cockpit/pilot assistance applications.
Target Recipient: Organizations and consortia involved in research and innovation within the aeronautics sector.
SECTOR-SPECIFIC: TRANSPORTATION (Aviation/Aerospace).
Geographic Scope: Organizations from EU Member States and countries associated with Horizon Europe (specific list not provided in these documents, refer to Annex B of the Work Programme General Annexes). The focus is on European civil aircraft.
Key Filtering Criteria: Focus on aircraft autonomy, cockpit/pilot assistance, and the development of new technologies up to TRL 4.
Grant Frequency: Part of the recurring Horizon Europe Work Programme (2021-2027), specifically Cluster 5 Call 03-2025. It aligns with the broader Clean Aviation Joint Undertaking's goals for climate-neutral aviation.

Funding

Up to 3500000.00 EUR

Deadline

April 14, 2026, midnight

Details

DigiQ Exchange Program

7622COMPETITIVE_CALLen

Programme: DigiQ: Digitally Enhanced European Quantum Technology Master

The core objective of the DigiQ Exchange Program is to provide financial support to Master's students in Quantum Technology, enabling them to undertake exchange semesters or thesis projects at partner institutions within the DigiQ network. - Target recipient type: Individual students, specifically those enrolled in a relevant Master Degree Programme. - Target recipient size: Individuals. - Designation: SECTOR-SPECIFIC (focused on Quantum Technology). - Geographic scope: European countries, specifically those where DigiQ partner institutions are located or eligible host countries are identified. - Key filtering criteria: Enrollment in a relevant Master's program, affiliation with or commitment to join the DigiQ network, and academic performance. - Grant frequency: The program runs year-round with ongoing applications until the program ends on September 30, 2026, making it a recurring opportunity.

Funding

Up to 6120.00 EUR

Deadline

March 31, 2026, 5 p.m.

Details

Funding to Attend DigiQ Networking Events

7621COMPETITIVE_CALLen

Programme: DigiQ: Digitally Enhanced European Quantum Technology Master

This grant provides financial support to students enrolled in or affiliated with the DigiQ network to attend in-person networking events.
The core objective is to enhance the education and networking opportunities for students in the field of quantum technology.
Target recipient type: Individual students.
Target recipient size: N/A, as it targets individuals.
This is a SECTOR-SPECIFIC grant, focused on quantum technology education and networking.
Geographic scope: Students must be associated with a DigiQ partner institution located in one of the eligible European countries.
Key filtering criteria for initial screening: Must be a student (current or recent graduate) affiliated with the DigiQ network.
Grant frequency: Recurring until September 30, 2026, when the overall DigiQ program concludes.
Program context: Part of the broader 'Digitally Enhanced European Quantum Technology Master' project (DigiQ), under the 'Specialised education programmes in key capacity areas' topic of the DIGITAL Europe Programme.

Funding

Up to 1000.00 EUR

Deadline

Sept. 30, 2026, midnight

Details

Making food systems more resilient to food safety risks through the deployment of technological solutions

HORIZON-CL6-2025-02-FARM2FORK-03-two-stage

Programme: Horizon Europe

The core objective of this grant is to enhance the resilience of food systems to food safety risks by deploying advanced technological solutions. It aims to translate existing knowledge into marketable results and impactful applications.

Target recipient: Organizations and actors across the entire food supply chain, including farming, raw materials suppliers, food processing, distribution, retail, and food services. SMEs are particularly encouraged.
SECTOR-SPECIFIC: This grant is highly specific to the food systems sector, encompassing agriculture, fisheries, aquaculture, and the broader food industry.
Geographic scope: Primarily EU Member States and countries associated with Horizon Europe. International cooperation is encouraged, especially with African partners, and engagement with widening countries, outermost regions, and Central/Eastern Europe is promoted.
Key filtering criteria for initial screening: Applicants must focus on innovative technological solutions for food safety and/or food fraud, aiming for high Technology Readiness Levels (TRL 8 by project end), and utilizing a multi-actor approach for broad stakeholder involvement.
Grant frequency: This opportunity is part of the Horizon Europe Work Programme 2025, indicating it is a recurring program within a larger funding framework.

Funding

Up to 6000000.00 EUR

Deadline

Feb. 18, 2026, midnight

Details

Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders

HORIZON-HLTH-2025-03-DISEASE-02-two-stage

Programme: Horizon Europe

This grant, HORIZON-HLTH-2025-03-DISEASE-02-two-stage, aims to advance innovative interventions for mental, behavioural, and neurodevelopmental disorders. Its core objective is to support research and innovation actions that lead to new, more effective, and safer therapeutic and relapse-preventing solutions, including those based on active substances and complementary multidisciplinary approaches. The grant explicitly targets scientific and clinical communities, encouraging participation from start-ups, micro, small, and medium-sized enterprises (SMEs), as well as broader legal entities involved in research. This is a SECTOR-SPECIFIC grant, focusing primarily on healthcare, life sciences, and related technology within the domain of brain health and mental health. The geographic scope includes EU Member States, Associated Countries (as defined by Horizon Europe Annex B), and the United States of America. Key filtering criteria for initial screening include a focus on clinical studies, novel therapeutic approaches, digital health solutions (including AI), and strong stakeholder engagement. Projects focusing on rare diseases (as defined by the EU Orphan Medicinal Products Regulation) are explicitly excluded. This grant is part of the Horizon Europe 2025 Work Programme, suggesting it is a recurring opportunity within the broader framework.

Funding

Up to 8000000.00 EUR

Deadline

April 16, 2026, midnight

Details

AI-Powered Signal Detection in Pharmacovigilance

HORIZON-JU-IHI-2025-11-03-two-stage

Programme: Innovative Health Initiative JU Call 11

Core Objective: To enhance drug safety and improve patient safety through the development and implementation of AI-powered signal detection and risk prediction methods in pharmacovigilance.
Target Recipient Type: Legal entities, including research organizations, universities, SMEs, and large enterprises.
Target Recipient Size: Not explicitly defined, open to various organizational sizes given the collaborative nature of research and innovation actions.
SECTOR-SPECIFIC
Geographic Scope: Primarily EU Member States and countries associated with Horizon Europe, excluding the UK and Canada for funding.
Key Filtering Criteria: Projects must focus on applying Artificial Intelligence to pharmacovigilance, specifically for signal detection and risk prediction. Emphasis is on research and innovation activities that lead to practical guidance and tools.
Grant Frequency and Program Context: This is a specific topic within the Innovative Health Initiative (IHI) Joint Undertaking's Call 11 (HORIZON-JU-IHI-2025-11-two-stage), which is part of the broader Horizon Europe framework. IHI calls are recurring within the Horizon Europe program.

Funding

Up to 8906000.00 EUR

Deadline

April 29, 2026, midnight

Details

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)

PAR-24-259

Programme: Small Instrumentation Grants Program (S15)

Core objective: To fund the purchase of latest scientific equipment to enhance and modernize the operations of existing shared biomedical research facilities, ultimately strengthening auxiliary activities and improving efficiency.
Target recipient type: Academic or research institutions.
Target size: Not specified by employee count, but implicitly institutions with established shared facilities.
Designation: SECTOR-SPECIFIC
Geographic scope: United States.
Key filtering criteria: Institution must operate an existing shared biomedical research facility, equipment must be for operational support (not direct scientific data acquisition), and only one type of equipment per application.
Grant frequency: Recurring annually with multiple submission cycles until September 2026.
Program context: Part of the NIH's S15 Small Instrumentation Grants Program.

Funding

Up to 350000.00 USD

Deadline

Sept. 25, 2026, 5 p.m.

Details

Vet-LIRN Network Capacity-Building Project and Equipment Grants

PAR-23-202

Programme: Department of Health and Human Services / U.S. Food and Drug Administration (FDA)

This grant, PAR-23-202, aims to fund veterinary diagnostic laboratories within the Vet-LIRN network for projects and equipment. The core objectives include supporting the development and validation of new methods related to animal food safety and antimicrobial resistance (AMR), conducting short-term monitoring, developing AMR stewardship projects, contributing to Vet-LIRN's AMR monitoring, and supporting One Health initiatives (e.g., emerging diseases, emergency surge capacity). This is a SECTOR-SPECIFIC grant primarily targeting established veterinary diagnostic laboratories. While not explicitly stated, the funding body (U.S. FDA) implies a U.S. geographic scope.

Funding

Up to 2500000.00 USD

Deadline

April 16, 2028, 3:59 a.m.

Details

Research Project: Innovation Grant

Onderzoeksproject: subsidie voor innovatie

Programme: VLAIO Innovation Subsidies

The core objective of this grant is to support businesses in Flanders to conduct frontier research ('grensverleggend onderzoek') that builds new knowledge, insights, and skills, leading to significant long-term positive impact for the company and for Flanders.
The grant targets enterprises with legal personality, non-profit organizations, and public organizations that undertake economic activity in the Flemish Region.
This grant is SECTOR-AGNOSTIC, with no preference for specific sectors, application domains, or knowledge areas.
Geographic scope is limited to organizations with operational activities (or clear intent to have them) in the Flemish Region of Belgium.
Key filtering criteria include the innovative nature of the project (must clearly deviate from normal business activities), a focus on knowledge building, and the project's potential for significant positive impact and valorization in Flanders.
This is a recurring grant program with applications being accepted on a permanent, open basis.